Hydroxychloroquine and Histrelin: Interaction Details
- Hydroxychloroquine
- PlaquenilSovuna
- Histrelin
- Supprelin
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Hydroxychloroquine and Histrelin interaction:
Hydroxychloroquine
- Plaquenil
- Sovuna
Histrelin
- Supprelin
We don't have a drug information page for Histrelin yet. Have a question about Histrelin? Ask a pharmacist, free →
What Happens When You Take Hydroxychloroquine With Histrelin
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
QT interval prolongation has been linked to hydroxychloroquine use,1 as have ventricular premature contractions and .3 Because effects on the , torsades de pointes among them, can be life-threatening and have been reported,4 hydroxychloroquine is not recommended for patients who are also receiving other drugs that may prolong the QT interval1 or that are arrhythmogenic.1
Electrolyte imbalances should be corrected before treatment begins, and cardiac function should be monitored during hydroxychloroquine therapy as clinically indicated. If is suspected, or is shown by tissue biopsy, hydroxychloroquine should be discontinued.2
The Hydroxychloroquine and Histrelin Interaction, Explained
Hydroxychloroquine (Plaquenil) is used for conditions like lupus, rheumatoid arthritis, or malaria. Histrelin (Supprelin) is a hormone-blocking implant, often used for early puberty or sometimes prostate cancer. Both can affect the heart's electrical rhythm, called the . Taking them together may add up and raise the chance of an abnormal heart rhythm, which can cause fainting or a fast, irregular heartbeat.
This does not mean you can't be treated. Your care team can check your heart and your blood salts (electrolytes) and decide what is safest. Please keep taking your medicines as prescribed and talk with your pharmacist or doctor about this combination, especially if you ever feel dizzy, faint, or notice a racing heartbeat.
Interaction: (). Hydroxychloroquine is associated with QT prolongation, ventricular premature contractions, and . Histrelin, a GnRH , may also prolong QT (androgen deprivation effect). Direction: increased proarrhythmic risk, not a PK change.
- Severity/evidence: Major, probable evidence; onset unspecified.
- Management: Combination is not recommended per labeling for QT-prolonging drugs. Correct electrolyte abnormalities (K, Mg, Ca) before use, monitor cardiac function (e.g., ) as clinically indicated, and consider alternatives if feasible.
- Discontinue hydroxychloroquine if is suspected or demonstrated.
See the 6 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Hydroxychloroquine and Histrelin Interact
The likely mechanism
How to Manage the Hydroxychloroquine and Histrelin Interaction
Hydroxychloroquine labeling says it is not recommended with other drugs that can prolong the , so your care team will weigh whether this combination is needed for you.
- Keep taking both medicines as prescribed unless your doctor tells you otherwise.
- Your team may correct low electrolytes before treatment and may monitor your heart more closely as needed.
- If heart effects are suspected, hydroxychloroquine may be stopped by your prescriber.
- Tell your pharmacist or doctor about all medicines you take and any heart rhythm history, fainting, or palpitations.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Hydroxychloroquine or Histrelin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
4 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)
An observational study examined patients treated for COVID-19 with hydroxychloroquine, with or without azithromycin. Patients given both drugs had a significantly greater rise in (+23 msec) than those given hydroxychloroquine alone (+5.5 msec).
One patient who received hydroxychloroquine together with azithromycin developed . Baseline QTc was significantly longer in the hydroxychloroquine-only group (474 msec) than in the group given hydroxychloroquine and azithromycin (442 msec).
Most patients had at least 1 cardiovascular comorbidity and were taking at least 2 QTc-prolonging agents. Note that COVID-19 itself may predispose patients to myocarditis or cardiomyopathy.4
-
Report 2 · Study title
Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit
In a case series of patients with COVID-19, the rate of increase to 500 msec or greater was significantly lower with hydroxychloroquine alone (5%) than with hydroxychloroquine plus azithromycin (33%). Half of the patients were also receiving other agents with the potential to prolong the . Most patients had some QTc increase during therapy overall, and no or cases of were reported.5
-
Report 3 · Study title
Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus
associated with hydroxychloroquine was reported in a 41-year-old woman with congestive heart failure and systolic left ventricular dysfunction. Her comorbidities included hypertension, systemic lupus erythematosus, and stage 5 chronic kidney disease.
A routine performed one week after hydroxychloroquine was restarted showed marked QT interval prolongation ( 614 msec). After hydroxychloroquine was discontinued, serial ECGs showed the QTc interval shortening. At follow up 1 year after discharge, her QTc was 473 msec.6
-
Report 4 · Study title
Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
and refractory ventricular were reported with long-term hydroxychloroquine use in a 67-year-old woman with systemic lupus erythematosus. She had been taking prednisoLONE, theophylline, and hydroxychloroquine 200 mg/day for 1 year.
Her medical history included cirrhosis, hepatitis B virus related hepatoma with protal vein thrombosis, and asthma. While at home, she suddenly lost consciousness and developed generalized rigidity.
She regained consciousness within minutes and had no complaints of chest pain, palpitation, limb weakness, incontinence, or confusion, but the episode recurred several times. On admission, the showed multiple ventricular premature contractions, , and QT interval prolongation.
Hydroxychloroquine was discontinued. With medical management, the ventricular arrhythmia subsided after 4 days and the shortened.3
Hydroxychloroquine and Histrelin: Common Questions
How serious is the Hydroxychloroquine and Histrelin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Hydroxychloroquine and Histrelin interaction managed?
Hydroxychloroquine labeling says it is not recommended with other drugs that can prolong the , so your care team will weigh whether this combination is needed for you. Keep taking both medicines as prescribed unless your doctor tells you otherwise. Your team may correct low electrolytes before treatment and may monitor your heart more closely as needed. If heart effects are suspected, h… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Hydroxychloroquine and Histrelin Interaction
Ask in your own words about taking Hydroxychloroquine and Histrelin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (6)
- Product Information: PLAQUENIL(R) oral tablets, hydroxychloroquine sulfate oral tablets. Concordia Pharmaceuticals Inc (per FDA), Kansas City, MO, 2021. DailyMed
- Product Information: SOVUNA(R) oral tablets, hydroxychloroquine sulfate oral tablets. ANI Pharmaceuticals, Inc. (per FDA), Baudette, MN, 2024. DailyMed
- Chen CY, Wang FL, & Lin CC: Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila) 2006; 44(2):173-175. DOI
- Mercuro NJ, Yen CF, Shim DJ, et al: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5(9):1036-1041. PubMed
- Bessiere F, Roccia H, Deliniere A, et al: Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit. JAMA Cardiol 2020; 5(9):1067-1069.
- Morgan ND, Patel SV, & Dvorkina O: Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus. J Clin Rheumatol 2013; 19(5):286-288. PubMed
Other Serious Interactions of Hydroxychloroquine and Histrelin
Also serious with Hydroxychloroquine
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PimozideContraindicated
- ThioridazineContraindicated
Also serious with Histrelin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Hydroxychloroquine
- GrapefruitMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- Slippery ElmModerate
- + 24 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.